Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis

American Journal of Pathology

Volumn 155, Issue 6, 1999, Pages 1985-1992

  De Marzo, Angelo M ^a,c   Marchi, Valerie L ^b   Epstein, Jonathan I ^a,b   Nelson, William G ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; ATROPHY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATECTOMY;

EID: 0032805744     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65517-4     Document Type: Article

References (58)

1. Ames BN: Mutagenesis and carcinogenesis: endogenous and exogenous factors. Environ Mol Mutagen 1989, 14:66-77
2. Weitzman SA, Gordon LI: Inflammation and cancer role of phagocyte-generated oxidants in carcinogenesis. Blood 1990, 76:655-663
3. Bartsch H, Frank N: Blocking the endogenous formation of N-nitroso compounds and related carcinogens. IARC Sci Publ 1996, 139:189-201
4. Smith CJ, Gardner WA Jr: Inflammation-proliferation: possible relationships in the prostate. Prog Clin Biol Res 1987, 239:317-325
5. Bennett BD, Richardson PH, Gardner WA: Histopathology and cytology of prostatitis. Prostate Diseases. Edited by H. Lepor and R. K. Lawson. Philadelphia, W. B. Saunders Company, 1993, pp 399-414
6. Bennett BD, Culberson DE, Petty CS, Gardner WA: Histopathology of prostatitis. J Urol 1990, 143:265A
7. Gardner WA, Bennett BD. The prostate-overview: recent insights and speculations. Pathology and Pathobiology of the Urinary Bladder and Prostate. Edited by RS Weinstein and WA Gardner Baltimore, Williams and Wilkins, 1992, pp 129-148
8. Platz EA: Prostatitis and prostate cancer. New Dev Prostate Cancer Treatment 1998, 3:71-73
9. De Marzo AM, Coffey DS, Nelson WG: New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia Urology 1999, 53:29-39
10. Franks LM: Atrophy and hyperplasia in the prostate proper. J Pathol Bacteriol 1954, 68:617-621
11. Liavag I: Atrophy and regeneration in the pathogenesis of prostatic carcinoma. Acta Pathol Microbiol Scand 1968, 73:338-350
12. McNeal JE: Normal histology of the prostate. Am J Surg Pathol 1988, 12:619-633
13. McNeal JE: Prostate. Histology for Pathologists, ed 2. Edited by SS Sternberg. Philadelphia, Lippincott-Raven, 1997, pp 997-1017
14. McNeal JE: Aging and the prostate. Urology in the Elderly. Edited by JC Brocklehurst. Edinburgh, Churchill Livingstone, 1984, pp 193-202
15. McNeal JE Regional morphology and pathology of the prostate. Am J Clin Pathol 1968, 49:347-357
16. Gardner WA Jr, Culberson DE: Atrophy and proliferation in the young adult prostate. J Urol 1987, 137:53-56
17. Billis A: Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol 1998, 11:47-54
18. Liavag I: Mitotic activity of prostatic epithelium. A study by means of Colcemid. Acta Pathol Microbiol Scand 1968, 73:19-28
19. Stiens R, Heipap B, Bruhl P: The proliferation of prostatic epithelium in chronic prostatitis. Urol Res 1975, 3:21-24
20. Ruska KM, Sauvageot J, Epstein JI: Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol 1998, 22:1073-1077
21. Bonkhoff H, Stein U, Remberger K: The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 1994, 24:114-118
22. McNeal JE, Haillot O, Yemoto C: Cell proliferation in dysplasia of the prostate: analysis by PCNA immunostaining. Prostate 1995, 27: 258-268
23. Bostwick DG: Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer 1996, 78:330-336
24. De Marzo AM, Nelson WG, Meeker AM, Coffey DS: Stem cell features of benign and malignant prostate epithelial cells. J Urol 1998, 160: 2381-2392
25. Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA: Colocalization of basal and luminal cell-type cytokeratins in human prostate career. Cancer Res 1992, 52:6182-6187
26. De Marzo A, Meeker A, Epstein J, Coffey D: Prostate stem cell compartments: expression of p27Kip1 in normal, hyperplastic and cancer cells. Am J Pathol 1998, 153:911-919
27. Yang RM, Naitoh J, Murphy M, Wang HJ, Phillipson J, deKernion JB, Loda M, Reiter RE: Low p27 expression predicts poor disease-free survival in patients with prostate cancer. J Urol 1998, 159:941-945
28. Cheville JC, Lloyd RV, Sebo TJ, Cheng L, Erickson L, Bostwick DG, Lohse CM, Wollan P: Expression of p27kip1 in prostatic adenccarcinoma. Mod Pathol 1998, 11:324-328
29. Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH. Slingerland JM: Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998, 58:542-548
30. Guc YP, Sklar GN, Borkowski A, Kyprianou N: Loss of the cyclin-dependent kinase inhibitor P27(Kip1) protein in human prostate cancer correlates with tumor grade. Clin Cancer Res 1997, 3:2269-2274
31. Cote RJ, Shi Y, Groshen S, Feng AC, Cordon-Cardo C, Skinner D, Lieskovosky G: Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J Natl Cancer Inst 1998, 90:916-920
32. Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI: Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst 1998, 90: 1284-1291
33. Coles B, Ketterer B: The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol 1990, 25:47-70
34. Rushmore TH, Pickett CB: Glutathione S-transferases, structure, regulation, and therapeutic implications. J Biol Chem 1993, 268:11475-11478
35. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB, Nelson WG: Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 1994, 91:11733-11737
36. Lee WH, Isaacs WB, Bova GS, Nelson WG: CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 1997, 6:443-450
37. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG: CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998, 7:531-536
38. Silberman MA, Partin AW, Veltri RW, Epstein JI: Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer 1996, 79:772-779
39. Cheville JC, Bostwick DG: Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma. Am J Surg Pathol 1995, 19:1068-1076
40. Oppenheimer JR, Wills ML, Epstein JI: Partial atrophy in prostate needle cores: another diagnostic pitfa I for the surgical pathologist. Am J Surg Pathol 1998, 22:440-445
41. Brawer MK, Peehl DM, Stamey TA, Bostwick DG: Keratin immunoreactivity in the benign and neoplastic human prostate. Cancer Res 1985, 45:3663-3667
42. Makin CA: Monoclonal antibodies raised to colorectal carcinoma antigens. Ann R Coll Surg Engl 1986, 68:298-301
43. Yang Y, Hao J, Liu X, Dalkin B, Nagle RB: Differential expression of cytokeratin mRNA and protein in normal prostate, prostatic intraepithelial neoplasia, and invasive carcinoma. Am J Pathol 1997, 150: 693-704
44. Kurki P, Ogata K, Tan EM: Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as prooes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Methods 1988, 109:49-59
45. Lynch BJ, Guinee DG Jr, Holden JA: Human DNA topoisomerase II-α a new marker of cell proliferation in invasive breast cancer. Hum Pathol 1997, 28:1180-1188
46. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LW, Hsieh JT, Tu SM, Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgenindependent prostate cancer. Cancer Res 1992, 52:6940-6944
47. Kyprianou N, Tu H, Jacobs SC: Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol 1996, 27: 668-675
48. Colombel M, Vacherot F, Diez SG, Fontaine E, Buttyan R, Chopin D: Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyoerplasia. Br J Urol 1998, 82:380-385
49. Bubendorf L, Sauter G, Moch H, Jordan P, Blochlinger A, Gasser TC, Mihatsch MJ: Prognostic significance of Bcl-2 in clinically localized prostate cancer. Am J Pathol 1996, 148:1557-1565
50. Bonkhoff H, Fixemer T, Remberger K: Relation between Bcl-2, cell proliferation, and the androgen receptor status in prostate tissue and precursors of prostate cancer Prostate 1998, 34:251-258
51. Canada AT, Roberson KM, Vessella RL, Trump DL, Robertson CN, Fine RL: Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissues. Biochem Pharmacol 1996, 51:87-90
52. Moskaluk CA, Duray PH, Cowan KH, Linehan M, Merino MJ: Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate Cancer 1997, 79:1595-1599
53. Cookson MS, Reuter VE, Linkov I, Fair WR: Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol 1997, 157:673-676
54. Blumenfeld W, Tucci S, Narayan P: Incidental lymphocytic prostatitis. Selective involvement with nonmalignant glands. Am J Surg Pathol 1992, 16:975-981
55. Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM, Schalken JA: Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 1988, 13:25-38
56. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170
57. Vlahos CJ, Kriauciunas TD, Gleason PE, Jones JA, Eble JN, Salvas D, Falcone JF, Hirsch KS: Platelet-derived growth factor incuces proliferation of hyperplastic human prostatic stromal cells. J Cell Biochem 1993, 52:404-413
58. Gleason PE, Jones JA, Regan JS, Salvas DB, Eble JN Lamph WW, Vlahos CJ, Huang WL, Falcone JF, Hirsch KS: Platelet derived growth factor (PDGF), androgens and inflammation: possible etiologic factors in the development of prostatic hyperplasia. J Urol 1993, 149: 1586-1592